IDXX vs. PODD: IDEXX Laboratories vs. Insulet Stock Comparison
How do IDEXX Laboratories (IDXX) and Insulet (PODD) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
IDEXX Laboratories (IDXX) and Insulet (PODD) are both classified in the Health Care Equipment sub-industry within the broader Health Care Equipment & Supplies industry, placing them in the closest GICS peer bucket.
| Profile Item | IDXX | PODD |
|---|---|---|
| Name | IDEXX Laboratories, Inc. | Insulet Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Equipment | Health Care Equipment |
| Market Capitalization | 53.26 billion USD | 10.16 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | Nasdaq |
| Listing Date | June 21, 1991 | May 15, 2007 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Total Return (1Y) | -1.84% | -53.25% |
| Total Return (3Y, Annualized) | 18.42% | -0.74% |
| Total Return (5Y, Annualized) | 2.02% | -14.02% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Volatility (1Y, Annualized) | 37.02% | 46.33% |
| Beta (5Y) | 1.44 | 1.04 |
| Max Drawdown (5Y) | -50.91% | -63.02% |
| Avg. Volume (3M) | 564.80K | 1.58M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Sharpe Ratio (1Y) | -0.17 | -1.24 |
| Sortino Ratio (1Y) | -0.28 | -1.51 |
Profitability
ROE (TTM)
Both companies show strong equity returns, but IDEXX Laboratories (IDXX) at 68.93% is the standout with ROE above its industry range; Insulet (PODD) at 28.94% also sits in the top quartile.
IDXX
Health Care Equipment & Services industry group
68.93%
- IDXX
- 68.93%
- Max
- 47.61%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
PODD
Health Care Equipment & Services industry group
28.94%
- Max
- 47.61%
- PODD
- 28.94%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both IDEXX Laboratories (IDXX) at 25.36% and Insulet (PODD) at 13.44% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
IDXX
Health Care Equipment & Services industry group
25.36%
- Max
- 29.35%
- IDXX
- 25.36%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
PODD
Health Care Equipment & Services industry group
13.44%
- Max
- 29.35%
- PODD
- 13.44%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both IDEXX Laboratories (IDXX) at 33.14% and Insulet (PODD) at 22.54% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
IDXX
Health Care Equipment & Services industry group
33.14%
- Max
- 35.43%
- IDXX
- 33.14%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
PODD
Health Care Equipment & Services industry group
22.54%
- Max
- 35.43%
- PODD
- 22.54%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | IDXX | PODD |
|---|---|---|
| ROE (TTM) | 68.93% | 28.94% |
| ROA (TTM) | 26.70% | 11.40% |
| Net Margin (TTM) | 25.36% | 13.44% |
| Operating Margin (TTM) | 33.14% | 22.54% |
| Gross Margin (TTM) | 62.72% | 71.88% |
Growth
Revenue Growth
Insulet (PODD) at 30.73% sits in the top revenue growth quartile, while IDEXX Laboratories (IDXX) at 10.42% is closer to the peer norm — faster top-line expansion for PODD.
EPS Growth
IDEXX Laboratories (IDXX) at 22.59% is around its peer norm for EPS growth, while Insulet (PODD) at -39.79% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Revenue Growth (YoY) | 10.42% | 30.73% |
| Revenue Growth (3Y CAGR) | 8.52% | 27.54% |
| EPS Growth (YoY) | 22.59% | -39.79% |
| EPS Growth (3Y CAGR) | 17.66% | 267.70% |
Financial Strength
Current Ratio (MRQ)
Insulet (PODD) at 2.51 keeps current ratio within its industry’s typical mid-range, while IDEXX Laboratories (IDXX) at 1.19 runs in the tighter-liquidity quartile — a thinner cushion against current liabilities for IDXX.
IDXX
Health Care Equipment & Services industry group
1.19
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- IDXX
- 1.19
- Min
- 0.30
PODD
Health Care Equipment & Services industry group
2.51
- Max
- 7.59
- Q3
- 4.00
- PODD
- 2.51
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both IDEXX Laboratories (IDXX) at 0.52 and Insulet (PODD) at 0.66 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
IDXX
Health Care Equipment & Services industry group
0.52
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- IDXX
- 0.52
- Q1
- 0.16
- Min
- 0.00
PODD
Health Care Equipment & Services industry group
0.66
- Max
- 1.88
- Q3
- 0.91
- PODD
- 0.66
- Median
- 0.58
- Q1
- 0.16
- Min
- 0.00
Financial Strength Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Current Ratio (MRQ) | 1.19 | 2.51 |
| Debt / Equity (MRQ) | 0.52 | 0.66 |
| Net Debt / EBITDA | 0.46 | 0.65 |
Dividends
Dividend Yield (TTM)
Neither IDEXX Laboratories (IDXX) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither IDEXX Laboratories (IDXX) nor Insulet (PODD) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
IDXX
Health Care Equipment & Services industry group
0.00%
- IDXX
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
PODD
Health Care Equipment & Services industry group
0.00%
- PODD
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | IDXX | PODD |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both IDEXX Laboratories (IDXX) at 45.56 and Insulet (PODD) at 23.94 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
IDXX
Health Care Equipment & Services industry group
45.56
- Max
- 80.41
- Q3
- 47.62
- IDXX
- 45.56
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
PODD
Health Care Equipment & Services industry group
23.94
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- PODD
- 23.94
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Insulet (PODD) at 3.19 prices around its industry’s typical P/S ratio, while IDEXX Laboratories (IDXX) at 11.42 clears its benchmark range — IDXX looks notably rich on sales.
IDXX
Health Care Equipment & Services industry group
11.42
- IDXX
- 11.42
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
PODD
Health Care Equipment & Services industry group
3.19
- Max
- 8.80
- Q3
- 4.32
- PODD
- 3.19
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Both look rich against book: Insulet (PODD) at 6.44 sits in the upper P/B ratio quartile, and IDEXX Laboratories (IDXX) at 28.50 prices even higher, above its industry range.
IDXX
Health Care Equipment & Services industry group
28.50
- IDXX
- 28.50
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
PODD
Health Care Equipment & Services industry group
6.44
- Max
- 11.68
- PODD
- 6.44
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | IDXX | PODD |
|---|---|---|
| P/E Ratio (TTM) | 45.56 | 23.94 |
| P/S Ratio (TTM) | 11.42 | 3.19 |
| P/B Ratio (MRQ) | 28.50 | 6.44 |
| Free Cash Flow Yield (TTM) | 2.00% | 1.12% |